Clinical Trials Directory

Trials / Completed

CompletedNCT06245811

Inflammation Markers in Hyperemesis Gravidarum

Evaluation of the Relationship Between Hyperemesis Gravidarum (HEG) With Platelet Crit (PCT), Haemoglobin to Red Cell Distribution Width Ratio (HRR) and Neutrophil to Lymphocyte Ratio (NLR).

Status
Completed
Phase
Study type
Observational
Enrollment
215 (actual)
Sponsor
Izzet Celegen · Academic / Other
Sex
Female
Age
18 Years – 45 Years
Healthy volunteers

Summary

In this study, the relationship between the severity of hyperemesis gravidarum (HEG) disease and subclinical inflammatory factors such as Platelet Crit (PCT), Hemoglobin/red cell distribution width ratio (HRR), Neutrophil/lymphocyte ratio (NLR), was investigated.

Detailed description

A total of 215 pregnant women, 102 with hyperemesis gravidarum and 113 healthy pregnant women, were included in the study. HEG patients were divided into three groups according to the modified PUQE classification: mild (n=38), moderate (n=32) and severe (n=32). In our study, we proposed using a new prognostic marker for HEG patients. We think that our study will be a source for future studies on HEG.

Conditions

Timeline

Start date
2022-01-20
Primary completion
2022-03-20
Completion
2022-06-20
First posted
2024-02-07
Last updated
2024-02-07

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT06245811. Inclusion in this directory is not an endorsement.